Mouse Anti-EIF4G1 Recombinant Antibody (2A9) (CBMAB-A2544-LY)


Basic Information
Application | Note |
IF(ICC) | 10 µg/ml |
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Cap-dependent translational initiation Source: ParkinsonsUK-UCL
Cellular macromolecule biosynthetic process Source: ParkinsonsUK-UCL
Cellular response to nutrient levels Source: ParkinsonsUK-UCL
Developmental process Source: ParkinsonsUK-UCL
Energy homeostasis Source: ParkinsonsUK-UCL
Negative regulation of autophagy Source: ParkinsonsUK-UCL
Negative regulation of neuron death Source: ParkinsonsUK-UCL
Negative regulation of peptidyl-threonine phosphorylation Source: ParkinsonsUK-UCL
Positive regulation of cell death Source: ParkinsonsUK-UCL
Positive regulation of cell growth Source: ParkinsonsUK-UCL
Positive regulation of cellular protein metabolic process Source: ParkinsonsUK-UCL
Positive regulation of eukaryotic translation initiation factor 4F complex assembly Source: ParkinsonsUK-UCL
Positive regulation of G1/S transition of mitotic cell cycle Source: ParkinsonsUK-UCL
Positive regulation of miRNA mediated inhibition of translation Source: ParkinsonsUK-UCL
Positive regulation of mRNA cap binding Source: ParkinsonsUK-UCL
Positive regulation of neuron differentiation Source: Ensembl
Positive regulation of peptidyl-serine phosphorylation Source: ParkinsonsUK-UCL
Positive regulation of translation in response to endoplasmic reticulum stress Source: UniProtKB
Regulation of cellular response to stress Source: ParkinsonsUK-UCL
Regulation of gene silencing by miRNA Source: ParkinsonsUK-UCL
Regulation of polysome binding Source: ParkinsonsUK-UCL
Regulation of presynapse assembly Source: ParkinsonsUK-UCL
Regulation of translational initiation Source: UniProtKB
Translation Source: ParkinsonsUK-UCL
Translational initiation Source: ParkinsonsUK-UCL
An autosomal dominant, late-onset form of Parkinson disease. Parkinson disease is a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain.
Following infection by certain enteroviruses, rhinoviruses and aphthoviruses, EIF4G1 is cleaved by the viral protease 2A, or the leader protease in the case of aphthoviruses. This shuts down the capped cellular mRNA transcription.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Rabbit Anti-EIF4G1 (phospho-S1108) Recombinant Antibody (EG1079) (CAT#: V2LY-0425-LY1770)
Rabbit Anti-EIF4G1 (Phospho-S1108) Recombinant Antibody (EG1078) (CAT#: CBMAB-EN1274-LY)
Rabbit Anti-EIF4G1 Recombinant Antibody (CBFYE-0732) (CAT#: V2LY-0425-LY1764)
Mouse Anti-EIF4G1 Recombinant Antibody (CBFYE-0734) (CAT#: CBMAB-E1167-FY)
Mouse Anti-EIF4G1 Recombinant Antibody (3A10) (CAT#: V2LY-0425-LY1768)
Mouse Anti-EIF4G1 Recombinant Antibody (CBFYE-0189) (CAT#: V2LY-0425-LY1763)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
